While the precise initiating mechanism leading to down regulation of PrKD1 in prostate cancer is unclear, the down regulated PrKD1 leads to loss of T120 phosphorylation of beta-catenin, which increases active nuclear beta-catenin with attendant consequences on downstream transcriptional activity. Here, PRKD1 is linked to prostate cancer.